Nyxoah SA
NYXH7.279USD
-0.021-0.29%
시장 운영 시간 （ET）시세는 15분 지연됩니다
272.43M시가총액
손실P/E TTM
자세한 내용은 Nyxoah SA 회사
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
회사 정보
종목 코드 NYXH
회사 이름Nyxoah SA
상장일Sep 18, 2020
CEOMr. Olivier Taelman
직원 수- -
유형Ordinary Share
회계 연도 종료Sep 18
주소Rue Edouard Belin 12
도시MONT-SAINT-GUIBERT
증권 거래소Euronext Brussels
국가Belgium
우편 번호1435
전화3226121755
웹사이트https://www.nyxoah.com/
종목 코드 NYXH
상장일Sep 18, 2020
CEOMr. Olivier Taelman
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.98M
+17.27%
Mr. John Landry
Mr. John Landry
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Loic Moreau
Mr. Loic Moreau
President - International
President - International
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Virginia Kirby
Ms. Virginia Kirby
Independent Director
Independent Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.98M
+17.27%
Mr. John Landry
Mr. John Landry
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Loic Moreau
Mr. Loic Moreau
President - International
President - International
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Virginia Kirby
Ms. Virginia Kirby
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sun, May 4
마지막 업데이트: Sun, May 4
주주
주주 유형
주주
주주
비율
Cochlear Limited
15.05%
Taub (Robert)
10.62%
Monden (Anneliese)
7.86%
Gilde Healthcare Partners B.V.
7.85%
Vestal Point Capital, LP
4.84%
Other
53.79%
주주
주주
비율
Cochlear Limited
15.05%
Taub (Robert)
10.62%
Monden (Anneliese)
7.86%
Gilde Healthcare Partners B.V.
7.85%
Vestal Point Capital, LP
4.84%
Other
53.79%
주주 유형
주주
비율
Individual Investor
22.07%
Corporation
19.66%
Investment Advisor/Hedge Fund
9.78%
Venture Capital
7.85%
Investment Advisor
7.20%
Hedge Fund
0.53%
Research Firm
0.03%
Other
32.87%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
69
25.12M
67.13%
-3.04M
2025Q1
70
26.40M
70.53%
-2.65M
2024Q4
73
25.60M
68.47%
-1.01M
2024Q3
72
23.51M
71.46%
-828.78K
2024Q2
72
23.54M
72.39%
-1.11M
2024Q1
64
20.89M
72.68%
+374.51K
2023Q4
59
21.08M
73.36%
-418.05K
2023Q3
66
19.86M
69.10%
-2.56M
2023Q2
66
20.66M
78.20%
+1.01M
2023Q1
68
20.34M
78.50%
+892.06K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cochlear Limited
5.63M
15.05%
--
--
Dec 31, 2024
Taub (Robert)
3.98M
10.62%
+585.48K
+17.27%
Dec 31, 2024
Monden (Anneliese)
2.94M
7.86%
--
--
Dec 31, 2024
Gilde Healthcare Partners B.V.
2.94M
7.85%
--
--
Dec 31, 2024
Vestal Point Capital, LP
1.81M
4.84%
-509.11K
-21.95%
May 21, 2025
ResMed Inc
1.73M
4.62%
--
--
Dec 31, 2024
Hambrecht (Jürgen)
1.34M
3.59%
--
--
Dec 31, 2024
Fidelity Management & Research Company LLC
1.11M
2.97%
-647.49K
-36.82%
Apr 29, 2025
BlackRock Financial Management, Inc.
965.58K
2.58%
-129.75K
-11.85%
Mar 31, 2025
BNP Paribas Asset Management Belgium S.A.
792.37K
2.12%
--
--
Aug 31, 2024
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Health Innovation Active ETF
0.12%
Avantis International Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SPDR Portfolio Europe ETF
0%
DFA Dimensional International Small Cap ETF
0%
Avantis International Small Cap Equity ETF
0%
iShares Health Innovation Active ETF
비율0.12%
Avantis International Equity ETF
비율0%
DFA Dimensional International Core Equity 2 ETF
비율0%
SPDR Portfolio Europe ETF
비율0%
DFA Dimensional International Small Cap ETF
비율0%
Avantis International Small Cap Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
